iSpecimen Inc. (ISPC) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

iSpecimen Inc. (ISPC)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.64

-0.04 (-1.49%)

At close: Jan 14, 2025, 3:59 PM

2.64

0.14%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	2.52
Market Cap	2.54M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-18.12
PE Ratio (ttm)	-0.15
Forward PE	n/a
Analyst	n/a

Ask	2.74
Volume	60,316
Avg. Volume (20D)	496,391
Open	2.61
Previous Close	2.68
Day's Range	2.60 - 2.79
52-Week Range	2.50 - 11.80
Beta	undefined

About ISPC

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Mark...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jun 17, 2021

Employees 53

Stock Exchange NASDAQ

Ticker Symbol ISPC

Website https://ispecimen.com

Next Earnings Release

iSpecimen Inc. is scheduled to release its earnings on Mar 12, 2025, before market opens.
Analysts project revenue of $43.55M, reflecting a 1.59K% YoY growth and earnings per share of -0.07, making a -98.97% decrease YoY.

Why Price Moved

4 months ago · Source

-23.14%

iSpecimen shares are trading lower after the compa... Unlock content with Pro Subscription

10 months ago · Source

-21.74%

iSpecimen shares are trading lower after the company reported worse-than-expected Q4 financial results.

News

3 weeks ago · newsfilecorp.com

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

Woburn, Massachusetts--(Newsfile Corp. - December 20, 2024) - iSpecimen Inc. (NASDAQ: ISPC), a leading online marketplace for human biospecimens, today announced its strategic initiatives for 2025, ex...

1 month ago · newsfilecorp.com

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

Woburn, Massachusetts--(Newsfile Corp. - December 13, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens...

1 month ago · newsfilecorp.com

iSpecimen Appoints Robert Lim as CEO and Director

Woburn, Massachusetts--(Newsfile Corp. - December 12, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens...

2 months ago · newsfilecorp.com

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Biospecimen Market To Exceed $13.5 Billion USD By 2032 Woburn, Massachusetts--(Newsfile Corp. - November 8, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marke...